SureTrader
Home > Boards > US OTC > Biotechs >

Amarantus Bioscience Holdings Inc. (AMBS)

AMBS RSS Feed
Add AMBS Price Alert      Hide Sticky   Hide Intro
Moderator: JPetroInc, zoomboom
Search This Board: 
Last Post: 1/19/2018 7:18:00 AM - Followers: 676 - Board type: Free - Posts Today: 0

 

(AMBS) Amarantus BioScience Holdings, Inc. 

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis.
The company has licensed Eltoprazine, a Phase 3 ready Parkinsons Levadopa induced Dyskinesia.

 (MANF) is a human growth factor that plays a key role in the prevention of apoptosis (cell death). It is being developed for the potential treatment of RP, Parkinson's disease, Wolfram syndrome, diabetes, Alzheimer's disease and traumatic brain injury.

ESS, previously known as PermaDerm®  is being developed to be the only tissue-engineered skin prepared from autologous (patient's own) skin cells consisting of both epidermal and dermal layers. A small harvested section of the patient's own skin can be grown to graft an area one hundred times its size in as little as thirty days. 
For further information, please visit www.Amarantus.com, or connect with the company in FacebookTwitter, LinkedIn & Google+
 
                                                                                       


 

NEWS



Bio-engineering skin to treat severe burns
 
 

   Videos

 

Gerald Commissiong, CEO of Amarantus BioScience Holdings, Inc. (OTCQX: AMBS) chats with Bob Power, OTC Markets VP of Corporate Services
Mar. 18, 2016

 
SNNLive with Amarantus Bioscience Holdings, Inc. (OTCQX: AMBS)  
December 2015


 

ESS Patients: Dr. Ahrenholz Interview Part 1 
 

ESS vs the Competition: Dr. Ahrenholz Interview Part 2

The Need for ESS: Dr. Ahrenholz Interview Part 3
 
 
 

 
                                                                                                                
 
 
    
       
 


                                                               Contact Information

Amarantus BioScience Holdings, Inc.
655 Montgomery Street
Suite 900
San Francisco, CA 94111

 

c/o ICS Corporate Services SA
29 quai du Mont Blanc
CH-1201 Geneva
Switzerland












 

info@amarantus.com
pr@amarantus.com


Phone: (415) 688-4484
Fax: (408) 852-4427


Gerald's email address
Gerald@amarantus.com



IR Calendar 






 

INVESTOR RELATIONS

Jenene Thomas Communications
Jenene Thomas
T: 908-938-1475

ir@amarantus.com


 

TRANSFER AGENT

VStock Transfer, LLC
Allison Niccols
77 Spruce Street
Suite 201
Cedarhurst, N 11516
T: 212-828-8436
F: 646-536-3179
info@vstocktransfer.com
www.VStockTransfer.com

 

 
 
                                                                            

 

SureTrader
AMBS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMBS News: Amarantus Provides Update on Capital Restructuring and Announces Participation in RESI JPM 2018 Convertible securities 01/09/2018 10:14:42 AM
AMBS News: Amarantus Subsidiary Cutanogen Corporation Announces Patent Issuance in Hong Kong Covering ESS, Pigmented ESS and Gene Therapy 01/04/2018 09:45:00 AM
AMBS News: Amarantus Subsidiary MANF Therapeutics Announces Patent Issuances in Europe and China Covering MANF as a Treatment and Biomar... 01/03/2018 08:00:00 AM
AMBS News: Amarantus Subsidiary MANF Therapeutics Announces Retinal Patent Issuances in Europe Covering MANF & CDNF and Positive Data for 12/26/2017 07:30:00 AM
AMBS News: Amarantus Subsidiary MANF Therapeutics Announces Issuance of Japanese Patent Covering Therapeutic Use of MANF in Treatment of 12/20/2017 08:45:00 AM
PostSubject
#126956   lol! Yeah, of the dead cat variety. SidVicious 01/19/18 07:17:59 AM
#126955   Bounce coming $AMBS jjr04001 01/18/18 08:02:12 PM
#126953   AMBS...099...Chart...Retrace from overbought position with a Marubozu Reversal georgie18 01/18/18 06:02:15 AM
#126952   The AMBS glass is 99% empty. That's a fact. SidVicious 01/17/18 09:18:39 PM
#126951   Some people look at a glass of water zoomboom 01/17/18 10:36:23 AM
#126950   But that is a convenient excuse to deflect SidVicious 01/17/18 10:27:40 AM
#126949   Some investors just have to step away and zoomboom 01/17/18 09:29:46 AM
#126948   I'm talking about the last two years when SidVicious 01/17/18 05:06:19 AM
#126947   What are you talking about? There is zoomboom 01/16/18 11:26:16 AM
#126946   We don't know just like we don't know SidVicious 01/16/18 11:21:15 AM
#126945   Been hearing that for a long time. zoomboom 01/16/18 11:12:57 AM
#126944   Surely hope Geraldo, the white collar criminal just SidVicious 01/16/18 11:10:59 AM
#126943   Just looks like some scarcely funded flippers zoomboom 01/16/18 11:05:40 AM
#126942   Why is AMBS dropping so much? Was this SidVicious 01/16/18 10:51:19 AM
#126940   The phrase "the boy who cried Wolf" is SidVicious 01/10/18 10:00:52 PM
#126939   lol good luck 2 u gulf shores man 01/10/18 02:31:57 PM
#126938   Just answering your question. You zoomboom 01/10/18 02:31:14 PM
#126937   how many times did we hear this over gulf shores man 01/10/18 02:29:58 PM
#126936   Here zoomboom 01/10/18 02:26:26 PM
#126935   After Becton Dickinson tested this stuff and headed gulf shores man 01/10/18 02:15:46 PM
#126934   $AMBS Daily and Weekly Charts http://www.stock $Pistol Pete$ 01/10/18 12:53:01 PM
#126933   I lost thousands of dollars on this stock gulf shores man 01/10/18 10:33:28 AM
#126932   Happy for you. zoomboom 01/09/18 05:28:57 PM
#126931   Ouch. Down 23%. Looks like Gerald can't keep SidVicious 01/09/18 05:28:07 PM
#126930   and if it isn’t ??? JPetroInc 01/09/18 04:00:37 PM
#126929   words well spoken TopKnotch JPetroInc 01/09/18 03:59:22 PM
#126927   Cool, keep us informed. I watch this stock mazennnn 01/09/18 03:02:07 PM
#126926   Already bouncing back up. Just zoomboom 01/09/18 02:57:18 PM
#126925   Let's hope so. mazennnn 01/09/18 02:55:55 PM
#126924   Unless a deal is struck at JPM $AMBS zoomboom 01/09/18 02:53:22 PM
#126923   Looks like this is still going lower. Next mazennnn 01/09/18 02:51:58 PM
#126921  Restored • The Binding LOIs contain certain provisions requiring TopKnotchTrades 01/09/18 02:21:51 PM
#126920   we don’t need an Angel JPetroInc 01/09/18 02:18:30 PM
#126918   the requirements of what? what are the requirements freegriff 01/09/18 01:40:35 PM
#126917   Ouch! Sounds like the price per share didn’t TopKnotchTrades 01/09/18 01:17:54 PM
#126916   Amarantus Provides Update on Capital Restructuring and Announces zoomboom 01/09/18 10:20:33 AM
#126914  Restored The biggest dump of them all was the SidVicious 01/09/18 09:19:07 AM
#126913   what's the difference JPetroInc 01/09/18 05:36:21 AM
#126912  Restored for better or worse, I expect the agreement freegriff 01/08/18 01:03:11 PM
#126910   pragmatic thoughts... JPetroInc 01/08/18 09:20:21 AM
#126909   I disagree JP. I think most investors are modest_investor 01/08/18 12:31:01 AM
#126907   Pfizer Ends Hunt for Drugs to Treat Alzheimer’s JPetroInc 01/07/18 10:27:18 AM
#126905   a lot of sells today JPetroInc 01/05/18 06:12:52 PM
#126904   Interesting joboggi 01/04/18 11:30:19 PM
#126903   How many times are AMBS IP assets going JPetroInc 01/04/18 12:59:11 PM
#126902   Garbage out and garbage in, as i see it. newflow 01/04/18 11:45:08 AM
#126901   News Out:Transfer of IP from AVDX to AMBS MikeCr 01/04/18 10:46:22 AM
#126900   News Out : Amarantus Subsidiary Cutanogen Corporation Announces zoomboom 01/04/18 09:56:29 AM
#126899   It will be a miracle if Amarantus ever SidVicious 01/03/18 08:39:00 PM
#126898   $AMBS Amarantus Subsidiary MANF Therapeutics Announces Patent Issuances $Pistol Pete$ 01/03/18 07:22:52 PM
PostSubject